Acceleron Pharma
XLRN
#1808
Rank
C$15.14 B
Marketcap
C$247.62
Share price
0.00%
Change (1 day)
14,732.66%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: C$15.14 Billion

As of December 2025 Acceleron Pharma has a market cap of C$15.14 Billion. This makes Acceleron Pharma the world's 1808th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022C$14.83 B6.47%
2021C$13.93 B41.74%
2020C$9.82 B167.19%
2019C$3.67 B34.04%
2018C$2.74 B13.7%
2017C$2.41 B86.45%
2016C$1.29 B-42.55%
2015C$2.25 B53.67%
2014C$1.46 B22.7%
2013C$1.19 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
C$239.62 B 1,482.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$103.25 B 581.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$672.92 B 4,343.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C$28.95 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.23 B-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
C$67.42 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$202.97 B 1,240.34%๐Ÿ‡บ๐Ÿ‡ธ USA